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Selvitimme keliakian diagnoosiviiveeseen liittyviä tekijöitä sekä keliakian Käypä hoito -suosituksen 
osuutta diagnoosiviiveen lyhenemiseen. 
 
Tämä retrospektiivinen kohorttitutkimus koostui 825 aikuisesta suolinäytteen perusteella 
diagnosoidusta keliaakikosta. Diagnoosi määriteltiin viivästyneeksi, kun kesto oireiden alkamisesta 
diagnoosihetkeen oli yli kymmenen vuotta. Tutkittavilta kerättiin tietoa oireiden tyypistä ja kestosta 
ennen diagnoosia, diagnoosipaikasta (primaari-, sekundaari- vai tertiaarisairaanhoito), 
diagnoosiajankohdasta, keliakian sukutaustasta sekä merkittävistä keliakiaan liittyvistä sairauksista. 
Analyysi toteutettiin binaarisella logistisella regressiolla. 
 
Yhteensä 261:lla (32%) 825:sta tutkittavasta oli yli kymmenen vuotta kestävä diagnoosiviive. 
Naissukupuoli, neurologinen tai tuki- ja liikuntaelinsairaus, ripuli, vatsakipu sekä imeytymishäiriöt 
olivat yhteydessä pitkittyneeseen viiveeseen. Miessukupuoli, diagnoosi keliakian Käypä hoito -
suosituksen julkistamisen jälkeen, seulottu keliakia sekä keliakian sukutausta olivat yhteydessä 
pienempään diagnoosiviiveen riskiin. Diagnoosipaikka, tutkittavan ikä, dermatitis herpetiformis, tyypin 
1 diabetes sekä kilpirauhassairaus eivät olleet yhteydessä diagnoosiviiveeseen. 
 
Viivästyneet keliakiadiagnoosit ovat vähentyneet viime vuosikymmeninä. Diagnostiikan siirtyminen 
erikoissairaanhoidosta perusterveydenhuoltoon ei ole vaikuttanut viiveeseen. Keliakian Käypä hoito -
suositus sekä aktiivinen riskiryhmien seulonta on vaikuttanut merkittävästi näihin tuloksiin. 
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ABSTRACT 
 
Objective. We here investigated the factors associated with long diagnostic delay in celiac disease and 
the impact of the national Current Care Guidelines in reducing the delay. 
Material and methods. This population-based study involved 825 adult celiac disease patients. The 
diagnosis was considered delayed when the interval between first symptoms and diagnosis was more 
than 10 years. The patients were asked about the duration and type of symptoms before diagnosis, time 
and site (tertiary, secondary or primary care) of the diagnosis, family history of the disease and 
presence of significant co-morbidities. Analysis was performed by binary logistic regression. 
Results. Altogether 261 (32%) out of 825 participants reposted a diagnostic delay of more than 10 
years. Female gender, neurologic or musculoskeletal disorders and presence of diarrhea, abdominal 
pain and malabsorption were associated with prolonged delay. Male gender, diagnosis after the 
introduction of the first Current Care Guidelines in 1997 and being detected by serologic screening and 
family history of celiac disease were associated with a lower risk of delayed diagnosis.  Factors not 
associated with the delay were site of diagnosis, age, presence of dermatitis herpetiformis, type 1 
diabetes or thyroidal disease. 
Conclusions.  The number of long diagnostic delays in celiac disease has decreased over the past 
decades. The shift of diagnostics from secondary and tertiary care to primary care has not been 
detrimental. National guidelines for the diagnosis and active screening in at-risk groups are important 
in these circumstances. 
 
Abbreviations: OR, Odds Ratio 
Key Words: Celiac disease, Diagnostic delay, Current Care Guidelines, Adults 
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INTRODUCTION 
 
In recent years the diverse clinical presentation of celiac disease has been recognized. Classical 
symptoms are diarrhea and poor growth or weight loss, but a variety of extraintestinal and atypical 
presentations are becoming increasingly common [1]. The heterogeneous clinical picture constitutes a 
challenge to physicians, and the average diagnostic delay is indeed very long, up to 12 years [2-7]. 
Besides the burden inherent in the ongoing symptoms, unrecognized celiac disease is associated with 
excessive use of health care services and on-demand medications [4, 8, 9]. Further, untreated disease 
predisposes to complications such as osteoporotic fractures [10], infertility [11, 12] and intestinal 
lymphoma [13, 14]. An early initiated gluten-free diet reduces the incremental burden to health care 
and the risk of complications and also improves health-related quality of life [2, 5, 8, 15]. 
 
In Finland, nationwide guidelines for the diagnosis and treatment of celiac disease were published in 
1997 and are regularly updated [16]. The primary aims of the guidelines were to increase the diagnostic 
yield and to shift diagnostics from secondary and tertiary centres to primary care. General practitioners 
in primary care are systematically trained to maintain a low threshold for celiac disease suspicion and 
recognize patients with mild or atypical symptoms [17]. A decrease in diagnostic delay is one expected 
consequence of the revised clinical practice [16, 18]. Indeed, since the guidelines were launched, the 
prevalence of biopsy-proven celiac disease has increased, now being up to 0.7 % in Finland [17, 19]. 
There is also evidence that the median diagnostic delay has shortened compared with the approximately 
10 years seen in many other countries, but even in Finland up to 25 % of patients have an unacceptable 
lag of 7-59 years [2-7]. Causes for the delay in diagnosis are complex and inadequately known [2]. 
 
We therefore set out to explore the factors underlying the long diagnostic delay in celiac disease. 
Particular attention was devoted to the connection between the national guidelines for celiac disease 
and the delay. 
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METHODS 
 
Participants and study design 
The study was conducted at Tampere University Hospital and the University of Tampere. First, adult 
patients diagnosed with biopsy-proven celiac disease were recruited by a nationwide search using 
newspaper advertisements and via local celiac disease societies. All celiac disease diagnoses had to be 
verified from the medical records. Exclusion criteria were uncertain diagnosis, diagnosis before the age 
of 18 years and lack of information reganrding date of diagnosis or duration of symptoms leading to it. 
Next, the eligible participants filled self-administered questionnaires and consented to phone 
interviews by a physician or a study nurse with expertise in celiac disease. Particular attention was paid 
to the duration and type of symptoms before diagnosis, date and place of diagnosis, family history of 
the disease and presence of celiac disease-associated co-morbidities such as type 1 diabetes and 
thyroidal disease, or other significant co-morbidities such as malignancy and neurological, psychiatric 
and musculoskeletal disease. According to baseline presentation, the patients were further categorized 
into 1. subjects with gastrointestinal (abdominal pain, diarrhea, abdominal distention, constipation, 
reflux, nausea, malabsorption, weight loss) symptoms; 2. subjects with extraintestinal (e.g. dermatitis 
herpetiformis, tiredness, neurological symptoms) symptoms, and 3. those who were detected by 
screening in at-risk groups. All self-reported retrospective information was verified from the subjects´ 
medical records. The diagnosis was considered substantially delayed if the disease-related symptoms 
had lasted more than ten years before diagnosis [5]. 
 
The study protocol was approved by the Ethics Committee of Tampere University Hospital. All study 
participants gave written informed consent. 
 
Statistics 
Binary logistic regression analysis was used to identify factors associated with delay as follows: First, 
univariable analysis was conducted with each variable in question. Next, multivariable analysis was 
performed with variables found to have significant association in the univariable analysis. The results 
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are presented as percentages and odds ratios (OR) with 95 % confidence intervals. A P value less than 
0.05 was considered statistically significant. All statistical calculations were performed using IBM 
SPSS Statistics 19 (New York, NY, USA). 
 
RESULTS 
 
Of the altogether 922 volunteers willing to participate, 825 were eligible and included in further 
analyzes. Of those who were excluded, 62 lacked information regarding the duration of symptoms 
before celiac disease diagnosis and 14 date of diagnosis; in 21 cases the diagnosis could not be 
verified. Median age at diagnosis was 44 (range 18-81) years, and 76% of the 825 participants were 
females. Gastrointestinal symptoms remained the main clinical presentation in 52% of males and 73% 
of females, while 24% and 9% evinced some extraintestinal presentation and 24% and 18% were 
detected by screening in at-risk groups (Table 1). Dermatitis herpetiformis was present in 23 % of 
males and 8 % of females. There was a strong secular trend in the site of diagnosis, as it has markedly 
shifted from tertiary centres to primary and secondary health care over time (Figure 1). 
 
 
Figure 1. Development of the site of celiac disease diagnosis over time. 
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Table 1. Association between clinical characteristics, place and time of diagnosis, presence of risk factors and delayed 
diagnosisa in 825 patients with celiac disease 
 n Diagnostic delay, % Odds ratio 95 % CI  P value 
Gender      
Male 198 23 1   
Female 627 34 1.79 1.23-2.59 0.002 
Clinical presentation      
Gastrointestinalb 559 35 1   
Extraintestinalc 106 30 0.80 0.51-1.25 0.316 
Screen-detectedd 160 20 0.46 0.30-0.70 <0.001 
Dermatitis herpetiformis      
Yes 95 28 1   
No 730 32 1.19 0.74-1.91 0.474 
Site of diagnosis      
Primary care 234 30 1   
Secondary care 389 30 1.00 0.69-1.41 0.944 
Tertiary care 199 36 1.30 0.87-1.95 0.198 
Calendar period of diagnosis       
2000- 415 27 1   
1990 – 1999 276 34 1.44 1.03-2.00 0.031 
1980 – 1989 101 45 2.20 1.41-3.45 0.001 
Before 1980 33 30 1.19 0.55-2.58 0.658 
Diagnosis after 1997e      
Yes 478 28 1   
No 347 37 1.55 1.15-2.09 0.004 
Celiac disease in family      
No 283 37 1   
Yes 537 28 0.68 0.50-0.93 0.014 
a Symptoms lasting 10 years or more before diagnosis of celiac disease 
b Diarrhea, abdominal pain or constipation, reflux, nausea, malabsorption 
c Dermatitis herpetiformis, tiredness, joint pains, neurological symptoms 
d Celiac disease in first-degree relatives, presence of autoimmune disorder 
e After the first national Current Care Guidelines for celiac disease 
CI, confidence interval 
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In total, 261 (32 %) out of 825 patients had diagnostic delay of 10 years or more. In univariable 
analysis female gender, celiac disease diagnosis before the year 2000 and diagnosis before the first 
national Current Care Guidelines was significantly associated with diagnostic delay (Table 1). In 
contrast, significant protecting factors were male gender, celiac disease detected by screening and 
family history of celiac disease. There was no association between long diagnostic delay and age at 
diagnosis, site of diagnosis or presence of dermatitis herpetiformis (Table 1).  
 
The association between concomitant clinical conditions and diagnostic delay in celiac disease is 
shown in Table 2. A significant association was found between long delay and the presence of 
musculoskeletal or neurologic disease. In contrast, there was no association between long delay and 
presence of concomitant psychiatric or gastroenterological disease, osteoporotic fracture, malignancy, 
type 1 diabetes or thyroidal disease (Table 2). 
 
Altogether 559 (68%) out of the 825 subjects reported gastrointestinal symptoms before the diagnosis. 
Presentations significantly associated with long delay were diarrhea, abdominal pain and 
malabsorption. In contrast, no association was seen between the delay and weight loss, abdominal 
distention, constipation, reflux and nausea (Table 3).  
 
In multivariable analysis, a statistically significant association was observed between long diagnostic 
delay and the presence of some musculoskeletal disorder (p = 0.014), abdominal pain (p < 0.001) and 
malabsorption (p < 0.001). There was also a non-significant trend towards a reduced proportion of 
delayed diagnoses after the introduction of the first Current Care Guidelines in 1997 (p = 0.063). 
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Table 2.  Association between presence of concomitant clinical condition and delayed diagnosisa in 
825 patients with celiac disease  
 
n 
Diagnostic 
delay, % 
Odds ratio 95 % CI P value 
Any malignancy      
No 781 32 1   
Yes 42 26 0.75 0.37-1.52 0.431 
Psychiatric disease      
No 790 30 1   
Yes 34 40 1.75 0.78-3.49 0.115 
Neurologic diseaseb      
No 718 30 1   
Yes 107 40 1.54 1.02-2.34 0.043 
Gastroenterological diseasec      
No 290 28 1   
Yes 535 39 1.28 0.95-1.74 0.108 
Musculoskeletal diseased      
No 570 28 1   
Yes 254 39 1.61 1.12-2.20 0.003 
Osteoporotic fracture      
No 792 31 1   
Yes 31 45 1.83 0.89-3.77 0.102 
Type 1 diabetes       
No 808 32 1   
Yes 17 29 0.90 0.31-2.58 0.842 
Thyroidal disease      
No 688 31 1   
Yes 137 34 1.16 0.79-1.71 0.462 
a Symptoms for 10 years or more before diagnosis of celiac disease 
The most common presentations were; b Transient ischemic attacks, dementia, neuropathy, migraine, 
epilepsy; c Lactose-intolerance, food allergy, gastro- esophageal reflux, diverticulosis, diaphragmatic 
hernia; d Osteoporosis or osteopenia, arthritis, fibromyalgia, discus prolapse 
CI, confidence interval 
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 Table 3. Association between the presence of different gastrointestinal symptoms before 
diagnosis and delayed diagnosisa in 825 patients with celiac disease 
 n 
Diagnostic 
delay, % 
Odds 
ratio 
95 % CI P value 
Diarrhea      
No 579 29 1   
Yes 246 38 1.53 1.12-2.09 0.008 
Weight loss      
No 701 31 1   
Yes 124 33 1.08 0.72-1.62 0.711 
Abdominal pain      
No 462 25 1   
Yes 363 40 1.98 1.47-2.67 <0.001 
Abdominal distension      
No 625 35 1   
Yes 200 31 1.19 0.85-1.67 0.317 
Reflux      
No 772 32 1   
Yes 53 26 0.76 0.41-1.43 0.399 
Constipation      
No 750 31 1   
Yes 75 36 1.24 0.76-2.04 0.395 
Malabsorption      
No 593 27 1   
Yes 232 45 2.27 1.64-3.10 <0.001 
Nausea      
No 52 32 1   
Yes 773 31 0.96 0.52-1.76 0.890 
a Symptoms for 10 years or more before diagnosis of celiac disease 
CI, confidence interval 
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DISCUSSION 
 
An important finding in the present study was that the proportion of subjects with a diagnostic delay of 
10 years or more in celiac disease has been significantly reduced within the past decades and also since 
the introduction of the first national guidelines for celiac disease in 1997. At the same time, the site of 
the diagnosis shifted markedly from secondary and tertiary to primary care. These findings, together 
with the fact that there was no significant difference in the prevalence of long delay between the 
different health-care sites, indicate that the regular and systematic training of primary care physicians 
in early recognition of celiac disease has been successful and encourages to continue [17, 18]. We 
believe that such a wide-scale decentralization of the diagnostics is a necessity, as the number of new 
celiac disease diagnoses is on a steep increase in most Western countries [20]. Furthermore, intensified 
awareness among health-care professionals and subsequent active case-finding has proved to be a cost-
effective alternative to population-based mass-screening in celiac disease [3]. Somewhat contradictory 
to our findings, some recent studies in other countries have indicated that non-gastroenterologists and 
other physicians with less expertise with celiac disease may have significantly poorer adherence to the 
published diagnostic guidelines for the condition than experts [21, 22]. These findings emphasize that 
the re-organization with possible decentralization of celiac disease diagnostics must be implemented in 
conjunction with a systematic education of physicians likely to encounter undetected celiac disease 
patients in their daily practice.  
 
In univariable analysis here we found several factors which were associated with long diagnostic delay 
in celiac disease, some of them being rather surprising. Quite opposite to our expectations, males were 
significantly less at risk of long delay than females. One explanation for this might be that a greater 
proportion of males than females were detected by serological screening in at-risk groups for celiac 
disease. Also, extraintestinal symptoms were almost three times more common in males and, even 
though there was no statistically significant difference here, can be easier to find. This can be due for 
example to the rather straightforward diagnosis of skin symptoms of dermatitis herpetiformis, which is 
more common among males [23]. Also, males in general seek less medical advice until disease-related 
symptoms become very severe [24]. Thus, even though males had long diagnostic delay less often than 
9 
 
 
females, it is possible that a higher proportion of males remain unrecognized. Moreover, particulary in 
female celiac disease patients the former irritable bowel syndrome diagnosis is common, this often in 
fact being unrecognized celiac disease with delayed diagnosis [25, 26]. 
 
Of concomitant medical conditions, the presence of a neurologic or musculoskeletal disease was 
significantly associated with a long diagnostic delay. As one plausible explanation here, it is likely that 
the presence of a previous serious disease distracts from diagnosis of another. In addition, several 
recent studies have shown that different neurological manifestations, such as ataxia and neuropathy are 
frequently implicated with celiac disease [27]. It is important that neurologists and general practitioners 
learn to know celiac disease as a possibility behind a patient’s unspecific neurological symptoms. 
Likewise, physicians should recognize that various musculoskeletal symptoms, such as joint pains and 
osteoporosis, are also common and possible the sole finding in celiac disease patients [28, 29]. 
 
It was surprising that one of the most characteristic and classic signs of celiac disease, malabsorption, 
increased the risk for long delay. Iron deficiency anemia is the most common form of malabsorption in 
celiac disease [1]. As it is often the only sign of untreated celiac disease, the presence of unexplained 
anemia should always lead to a suspicion and prompt exclusion of the disorder [30, 31]. Similarly to 
malabsorption, other particulary typical symptoms of untreated celiac disease, diarrhea and abdominal 
pain, were associated with excessive delay in the present study; abdominal pain remained significant 
even after multivariable analysis. This rather unexpected result might be partly explained by a recall 
bias in the retrospective design, as the duration of these burdensome and typical symptoms of celiac 
disease is easily overestimated compared to milder or atypical symptoms. More research is evidently 
needed to confirm these unexpected associations. 
 
Strengths of the present study were the nationwide approach and the large number of participants with 
well-verified biopsy-proven celiac disease. Further, the clinical data were collected meticulously both 
by expert interviews and from medical records. The variable clinical presentation of celiac disease was 
also taken into account. Nevertheless, there were also certain limitations. First, the majority of study 
subjects were members of patient support organizations, which might have caused selection bias. On 
the other hand, approximately 70 % of all celiac disease patients in Finland are members of such 
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organizations; we thus believe our results to be representative [17, 33]. Second, the retrospective design 
and long period of time covered by the study made it vulnerable to a number of confounding factors; 
also only a few associations remained significant after multivariable analysis. The threshold of 10 years 
or more used here for considerably delayed diagnosis is also somewhat artificial; however, we would 
maintain that such a long delay is in any case unacceptable. There is moreover evidence that a delay 
this long is associated with the development of celiac disease-associated malignancies [5].  The precise 
impact of the national Current Care Guidelines in this progress could not be evaluated even though the 
directives are a possible factor in reducing the diagnostic delay. Nevertheless, these guidelines are 
intended mainly for the general practitioners, and we believe that they will augment the diagnostics at 
population level.  
 
To conclude, an unacceptably long diagnostic delay in celiac disease has become less common in 
Finland over the past decades. It was surprising that the classic diagnostic clues to celiac disease, 
gastrointestinal symptoms and malabsorption, did not reduce but on the contrary were associated with 
a higher risk of long diagnostic delay. The shift of diagnostics from secondary and tertiary to primary 
care has not resulted in longer delays. National guidelines for the diagnosis of celiac disease are 
important in these circumstances. 
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